|

Single Agent Asciminib Clinical Trials

1 actively recruiting trial across 1 location

No change since June 2026

Also known as: ABL001

Pipeline

Phase 2: 1

Top Sponsors

  • University of Alabama at Birmingham1

Indications

  • Adult CML1
  • Chronic Myeloid Leukemia, Chronic Phase1
  • Leukemia, Myeloid1
  • Leukemia,Myeloid, Chronic1
  • Cancer1

Birmingham, Alabama1 trial

Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase

University of Alabama at Birmingham

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.